@goedy the market cap of RHY is around $74 million as of close yesterday. Your stated $40 million is incorrect.
Your conspiracy theories about leak of information about TGA approval to friends, family, colleagues etc is ridiculous.
If you ask our dear friend
@ShmoShady who claims to have access to a Bloomberg Terminal (that costs $30,000 of which his employer owns
) he will be able to tell you that the top 20 as at 31 January and as at 30 April not one shareholder has sold any shares. I know it sounds unbelievable but trust me it's true. I will not divulge in how I was able to obtain that information.
If Glenn Gilbert was really a dud, why would Signature Oncology hire him? Something was/is clearly not right at RHY. That's my opinion.
Signature Oncology board has some pretty impressive resumes on paper. Any capital raise might result in multiple gains if they list on ASX in the future. It probably should've read seed capital rather than capital raise.
@josiejow37 as per above the only selling of RHY shares are from shareholders outside the top 20.
Top 20 comprises of just under 90 million shares as at 30 April so shareholders outside of top 20 which accounts for approximately 124 million shares.
That's a lot of shareholders outside the top 20 that can sell this stock down to single digits.
I know it sounds unbelievable but many stocks on ASX have done this. I can't find any examples for you but if you look for a speculative stock that has roared up and fell back down to earth most times the top 20 is little changed.
@Loyalists, trust me if I tell you there is a competing product that is protein based and is currently being used in European hospitals and is for population screening.
Remember when I posted this? You all didn't believe me and gave me a very hard time and continue to do so. Do some decent research you die hards. You know who you are.
